Home›Companies›Biotech & Pharma›Bryleos

BioNADrx Holdings, Inc.

Develops oral programs using molecules found in the body.

Updated Nov 20, 2026·Latest SEC filing Jan 30, 2024·Suggest an edit

About Bryleos

Bryleos is a private company based in Johnson City, Tennessee, incorporated in 2021 in Delaware. It has reported $125,000 raised in one offering on Form D since January 2024. Its chief executive is Wendy Kormac.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 30, 2024Jan 30, 2024$125,000of $10.0M target1$125KOptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bryleos's Form D filed Jan 30, 2024.

PM
FP
Filip Pinter
Chief Financial Officer and A Director
WK
Wendy Kormac
Chief Executive Officer and A Director

Sources

  1. SECBioNADrx Holdings, Inc. filing history
  2. CompanyBryleos privacy and cookie policy